Atlas Trials

Evaluation of MorphoTEP With the FDG Among Patients in Severe Sepsis of Unspecified Etiology

Clinical trial NCT00791310 · UNKNOWN

Trial details

NCT number
NCT00791310
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Severe Sepsis
Start date
2008-11-01
Primary completion
2010-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.